Friday, July 10, 2026

pharma · Not applicable, Healthy Volunteers · advanced/metastatic non-squamous non-small cell lung cancer (NSCLC)

mAbxience

mAbxience trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

madrid, ES HQ
2009 Founded
1,194 Employees
EMA registrant Type
Company details
Status
Public
HQ
madrid, ES
Founded
2009
Employees
1,194
Programs
5
Drugs
10
Patents
0
Intelligence · Clinical Trials

mAbxience clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to mAbxience programs — each row shows trial ID, program name, phase, status, and indication.

mAbxience trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for mAbxience.

  1. MB04-A-01-23 — Phase 1

    Clinical update
  2. MB12-C-02-24 — Phase 3

    Clinical update
  3. MB11-C-01-25 — Phase 3

    Clinical update
  4. MB04-C-01-23 — Phase 3

    Clinical update
  5. MB02-SP — Phase 1

    Clinical update

Trial registry

5 studies